Latest Headlines

  1. Bora Appoints Industry Veteran As Chief Commercial Officer 5/13/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, today announced the appointment of Jean-Baptiste (“JB”) Agnus as Chief Commercial Officer.

  2. NanoTemper Announces Prometheus Panta C: Powering Biopharma Breakthroughs From Preclinical To Commercial Manufacturing 5/12/2025

    NanoTemper Technologies today introduces Prometheus Panta C, a system built to power biopharma breakthroughs by delivering high-quality protein stability and aggregation data.

  3. Andelyn Biosciences Applies The AAV Curator® Platform To Deliver Novel Gene Therapy For An Ultra-Rare NEDAMSS Disease Patient 14-Months After Diagnosis 5/12/2025

    Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has successfully manufactured a novel viral vector gene therapy with its AAV Curator® Platform to treat a baby with the ultra-rare disease Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and Seizures (NEDAMSS).

  4. VintaBio Unveils New Data Showcasing Scalable AAV Perfusion Manufacturing Platform With High Full Capsid Yield At 2025 ASGCT Annual Meeting 5/8/2025

    VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its proprietary VintaProcess™, an advanced intensified adherent viral vector manufacturing platform.

  5. Minaris Advanced Therapies Launches As The Leading Global Partner Dedicated To Cell Therapy Development, Manufacturing, And Testing 5/7/2025

    Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi Advanced Therapies have been combined to form Minaris Advanced Therapies, a global cell therapy CDMO and testing partner.

  6. Merck Breaks Ground On New Biologics And ADC Manufacturing Facility In Delaware 4/29/2025

    Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.

  7. RoosterBio Announces Collaboration With Thermo Fisher Scientific To Advance Cell And Exosome Therapy Manufacturing 4/29/2025

    RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science.

  8. Cytiva And Asimov Collaborate On Next Generation Cell Line Design And Process Development 4/29/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an integrated offering for optimized biologics production.

  9. Alconox Announces Extended Shelf Life Of Critical Cleaning Detergents For Life Sciences 4/24/2025

    Alconox Inc. is pleased to announce that we have extended the shelf life of our critical cleaning detergents from 2 years (24 months) to 3.5 years (42 months). This significant improvement in shelf life is based on extensive stability testing, and our goal of continuous improvement. Thus ensuring the continued reliability and performance of our detergents throughout this extended period.

  10. Nikon CeLL Innovation Enters Into A Strategic License Agreement With RoosterBio 4/15/2025

    Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBio), a leading stem cell technology company in the US.